TELECONFERENCE

Reducing the Risk of Patient Harm with Anticoagulant Therapy

Registration for the teleconference has expired.

PROGRAM OVERVIEW This teleconference will provide you with the building blocks necessary to define and implement an anticoagulant management program in your hospital, as required by one of the new Joint Commission (TJC) National Patient Safety Goals for 2008. With a special focus on heparin and warfarin, speakers from the Institute for Safe Medication Practices (ISMP) will describe the causes of harmful errors with these anticoagulants and present core and target best practices related to: • Patient assessment and prescribing of anticoagulants • Monitoring of therapy • Use of reversal agents • Dosing and calculation errors • Patients receiving duplicate or concurrent therapy • Mistakes due to similar labeling and packaging • Adverse drug reactions and drug interactions • Mistakes due to look-alike and sound-alike drug names, • Lack of standardization of drug concentrations • Drug storage issues. ISMP speakers will also provide examples of measures that can be used to evaluate anticoagulation safety practices in your facility. Organizations that are participating in the Protecting 5 Million Lives From Harm Campaign will also benefit from learning more about how to prevent harm from these targeted high-alert medications and ways to measure your success.

INTENDED AUDIENCE (Interdisciplinary teams are encouraged to attend together):

• Medication Safety and Patient Safety Officers
• Nurses
• Pharmacists
• Physician Assistants
• Physicians
• Risk and Quality Managers

OBJECTIVES

Following completion of this teleconference, participants should be able to:

• Describe common preventable adverse events with anticoagulants and their causes
• Identify best practices that can improve safety when prescribing, dispensing, and administering anticoagulants
• Discuss the role of the practitioner in monitoring and managing the care of patients who are receiving anticoagulants
• Construct two measures that can be used to assess the safety of anticoagulant therapy

MODERATOR

• Matthew Fricker, RPh, MS, Program Director, Institute for Safe Medication Practices

SPEAKERS

• Matthew Fricker, RPh, MS, Program Director, Institute for Safe Medication Practices
• Matthew Grissinger, RPh, FASCP, Director, Error Reporting Programs, Institute for Safe Medication Practices

PRICING INFORMATION

Live Teleconference	$195.00
Live Teleconference and Teleconference CD	$225.00 (Plus $5.00 S&H)
Teleconference CD	$195.00 (Plus $5.00 S&H)
*CD includes a file of the audio recording of the teleconference as well as PowerPoint files containing slides of each presentation.

TELECONFERENCE POLICIES

Registration

• One telephone line connection is allowed per registration. Others may listen on this telephone line via an internal extension, or a speakerphone may be used for larger groups.
• You may not set up conferencing capabilities for other sites outside the facility. Each specific site may be used for larger groups. Each specific site must register individually.
• We cannot accept registrations without an email address and the name of a contact person.
• Registration for this teleconference will end at midnight ET on 9/18/2007.
• CDs will be available for purchase after the teleconference.

Cancellations

• Cancellations must be requested via an email message to our teleconference department.
• Cancellations received before the start (1:30 pm ET) of the teleconference will receive a full refund or credit.
• Cancellations received after the start (1:30 pm ET) of the teleconference and within 3 business days after the teleconference will be assessed a cancellation fee of $50.00.
• If your organization does not cancel within 3 business days after the date of the teleconference and does not participate, the full registration fee will be charged.

Materials

• If your organization's registered participant does not receive the teleconference materials that are sent out approximately 2 days before the teleconference via email, please send an email message to our billing department prior to the start of the teleconference.
  
• When registering, please be sure to provide the email address of the person to whom ISMP should send these materials.

---

Accreditation Information:

NOTE: There is no additional charge for continuing education credits for this teleconference.

Pharmacy Continuing Education Continuing education credits will be provided by The Pediatric Pharmacy Advocacy Group. PPAG is an approved provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education (ACPE). This program has been approved for 1.5 contact hours (0.15 CEUs). The UPN is: 180-999-07-510-L05-P. Nursing Continuing Education Debora Simmons is approved by the California Board of Nurse Examiners as a provider of continuing nursing education. This program has been assigned the Universal Program Number CEP 13677 and is approved for 1 contact hours (0.1 CEUs) of continuing nursing education.